RAPT THERAPEUTICS INC's ticker is RAPT and the CUSIP is 75382E109. A total of 86 filers reported holding RAPT THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 1.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,381,249 | -17.8% | 383,950 | -7.5% | 0.00% | -50.0% |
| Q2 2023 | $7,764,894 | +13.0% | 415,235 | +10.9% | 0.00% | +100.0% |
| Q1 2023 | $6,871,066 | -26.2% | 374,445 | -20.3% | 0.00% | -50.0% |
| Q4 2022 | $9,306,396 | -26.7% | 470,020 | -11.0% | 0.00% | -33.3% |
| Q3 2022 | $12,704,000 | +70.8% | 527,997 | +29.6% | 0.00% | +50.0% |
| Q2 2022 | $7,436,000 | +296.0% | 407,489 | +377.1% | 0.00% | – |
| Q1 2022 | $1,878,000 | +170.6% | 85,418 | +351.9% | 0.00% | – |
| Q4 2021 | $694,000 | -44.0% | 18,900 | -52.7% | 0.00% | – |
| Q3 2021 | $1,240,000 | -85.8% | 39,923 | -85.5% | 0.00% | -100.0% |
| Q2 2021 | $8,724,000 | +253.6% | 274,400 | +147.0% | 0.00% | – |
| Q1 2021 | $2,467,000 | +11.9% | 111,100 | -0.4% | 0.00% | – |
| Q4 2020 | $2,204,000 | – | 111,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Column Group LLC | 2,680,621 | $49,189,395 | 17.79% |
| Euclidean Capital LLC | 432,900 | $7,943,715 | 6.97% |
| GREAT POINT PARTNERS LLC | 1,355,151 | $24,867,021 | 4.88% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 875,984 | $16,074,306 | 3.02% |
| Trustees of Columbia University in the City of New York | 80,580 | $1,478,643 | 2.64% |
| Perceptive Advisors | 2,291,608 | $42,051,007 | 1.24% |
| Cormorant Asset Management, LP | 650,000 | $11,928 | 0.79% |
| Alphabet Inc. | 540,270 | $9,913,955 | 0.55% |
| Redmile Group, LLC | 688,132 | $12,627,222 | 0.55% |
| Orbimed Advisors | 1,251,070 | $22,957,135 | 0.45% |